Product News
H.E.L. Adds to Senior Management Team
H.E.L. Group has announced the strengthening of the Company’s senior management team with Paul Orange, Ph.D. joining as Chief Marketing Officer (CMO), and Paul Sturgeon as Chief Financial Officer (CFO).
Product News
Edpidarex Exeed Aims To Advance Innovation in Drug Discovery
Epidarex’s therapeutic discovery engine aims to identify innovative early stage assets, providing hands-on scientific support and funding to drive drug discovery projects.
Product News
Compact Nitrogen Blowdown Evaporator
The MiniVap® Nitrogen Blowdown evaporator from Porvair Sciences is purpose-designed for research and development departments where low numbers of individual microplates or vials need drying.
Product News
Drug Therapy for Demyelinating and Neuroinflammatory Diseases Given US Patent
MetP Pharma has announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for its patent entitled “Treatment of Demyelinating Diseases”.
Product News
ScreenIn3D Wins ELRIG Drug Discovery Innovation Prize
ScreenIn3D, a partner of AMSBIO, has been awarded the ELRIG Prize for Innovation in Drug Discovery at their flagship conference Drug Discovery 2019.
Product News
Pre-approval Access Collaboration for Novel Cancer Therapeutic
Onconova and Inceptua Medicines Access have announced that they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.
Product News
“One-Stop Metabolite Shop” For Pharmaceutical and Agrochemical Research and Development
Hypha Discovery has launched its “One-Stop Metabolite Shop” to provide a complete solution for provision of small molecule drug metabolites to pharmaceutical and agrochemical companies worldwide.
Product News
Success in Global Challenge To Find Novel Antimalarial Compounds
Intellegens and Optibrium™ have announced joint success in the Open Source Malaria (OSM) global initiative aimed at identifying the best predictive models for antimalarial compounds.
Product News
Accelerating Neuroscience-focused Ion Channel Drug Discovery
Metrion and LifeArc have announced an extension of their neuroscience-focused ion channel drug discovery collaboration, following the success of the initial twelve-month agreement.
Product News
Further Investment in Developing Next-generation Anticoagulants
LUNAC Therapeutics (LUNAC) has been awarded £3.14M under Innovate UK’s Biomedical Catalyst programme, to help develop a next-generation anticoagulant.
Advertisement